[go: up one dir, main page]

HK1205933A1 - Enhanced stability phenylephrine liquid compositions - Google Patents

Enhanced stability phenylephrine liquid compositions Download PDF

Info

Publication number
HK1205933A1
HK1205933A1 HK15106451.2A HK15106451A HK1205933A1 HK 1205933 A1 HK1205933 A1 HK 1205933A1 HK 15106451 A HK15106451 A HK 15106451A HK 1205933 A1 HK1205933 A1 HK 1205933A1
Authority
HK
Hong Kong
Prior art keywords
composition
phenylephrine
aldehyde
amount
polyethylene glycol
Prior art date
Application number
HK15106451.2A
Other languages
English (en)
Chinese (zh)
Inventor
威廉．布勃尼斯
斯特凡妮．希爾德
斯特凡妮．希尔德
蓋爾．
盖尔．P．霍斯科韦茨
．霍斯科韋茨
Original Assignee
惠氏公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38814551&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1205933(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 惠氏公司 filed Critical 惠氏公司
Publication of HK1205933A1 publication Critical patent/HK1205933A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
    • A61K31/37—Coumarins, e.g. psoralen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Emergency Medicine (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK15106451.2A 2006-07-14 2009-11-25 Enhanced stability phenylephrine liquid compositions HK1205933A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11/487,120 US20080014274A1 (en) 2006-07-14 2006-07-14 Enhanced stability phenylephrine liquid compositions
US11/487,120 2006-07-14

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK09110993.7A Addition HK1131068A (en) 2006-07-14 2007-07-11 Enhanced stability phenylephrine liquid compositions

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK09110993.7A Division HK1131068A (en) 2006-07-14 2007-07-11 Enhanced stability phenylephrine liquid compositions

Publications (1)

Publication Number Publication Date
HK1205933A1 true HK1205933A1 (en) 2015-12-31

Family

ID=38814551

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15106451.2A HK1205933A1 (en) 2006-07-14 2009-11-25 Enhanced stability phenylephrine liquid compositions

Country Status (26)

Country Link
US (1) US20080014274A1 (fr)
EP (2) EP2040672B1 (fr)
JP (1) JP2009543777A (fr)
KR (2) KR20140088234A (fr)
CN (2) CN104546671A (fr)
AR (1) AR061985A1 (fr)
AU (1) AU2007272961B2 (fr)
BR (1) BRPI0714399B8 (fr)
CA (1) CA2657611A1 (fr)
CO (1) CO6180496A2 (fr)
EC (1) ECSP099072A (fr)
ES (2) ES2550036T3 (fr)
HK (1) HK1205933A1 (fr)
HU (2) HUE025790T2 (fr)
IL (1) IL196447A (fr)
MX (1) MX2009000530A (fr)
NZ (1) NZ574148A (fr)
PE (1) PE20081003A1 (fr)
PL (2) PL2040672T3 (fr)
PT (2) PT2040672E (fr)
RU (1) RU2468787C2 (fr)
SG (2) SG10201408522UA (fr)
TW (1) TW200812640A (fr)
UY (1) UY30484A1 (fr)
WO (1) WO2008008364A2 (fr)
ZA (1) ZA200900315B (fr)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
JP5175278B2 (ja) * 2006-06-01 2013-04-03 エムエスディー コンシューマー ケア， インコーポレイテッド 結腸吸収のためのフェニレフリン薬学的製剤および組成物
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
CA2653950A1 (fr) * 2006-06-01 2007-12-13 Schering Corporation Formulations et compositions pharmaceutiques a liberation pulsee de phenylephrine
AU2007254826B2 (en) * 2006-06-01 2013-10-24 Merck Sharp & Dohme Corp. Pharmaceutical compositions for sustained release of phenyephrine
US20080299186A1 (en) * 2007-06-01 2008-12-04 Schering-Plough Healthcare Products, Inc. Coatings for applying substances onto substrate carrier
PE20091084A1 (es) * 2007-12-07 2009-07-23 Schering Plough Healthcare Formulaciones farmaceuticas de fenilefrina y composiciones para absorcion transmucosal
US8518439B2 (en) * 2008-12-03 2013-08-27 Novartis Ag Liquid therapeutic composition
CA2690488C (fr) * 2010-01-19 2013-06-11 Accucaps Industries Limited Formulations pharmaceutiques de naproxen pour encapsulation molle et combinaisons associees
CA2802362C (fr) * 2010-06-11 2017-11-21 Gm Pharmaceuticals, Inc. Compositions pharmaceutiques destinees a soulager la congestion respiratoire des voies superieures et la congestion oropharyngee
JP6013346B2 (ja) 2010-10-21 2016-10-25 アールティーユー ファーマシューティカルズ， エルエルシー 即時使用可能なケトロラク製剤
FR2987268B1 (fr) 2012-02-28 2014-07-11 Ammtek Formulations liquides de sulfamides hypoglycemiants
PL2961377T3 (pl) * 2013-02-28 2020-11-02 Pf Consumer Healthcare 1 Llc Zwiększona stabilność nowych ciekłych kompozycji
US10195153B2 (en) 2013-08-12 2019-02-05 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (fr) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Comprimé extrudé anti-abus à libération prolongée
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
AU2015290098B2 (en) 2014-07-17 2018-11-01 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
CA2964628A1 (fr) 2014-10-20 2016-04-28 Pharmaceutical Manufacturing Research Services, Inc. Forme galenique anti-abus de remplissage de liquide a liberation prolongee
GB201506755D0 (en) 2015-04-21 2015-06-03 Reckitt Benckiser Llc Novel pharmaceutical formulation
JP5918895B1 (ja) * 2015-05-21 2016-05-18 富士カプセル株式会社 ナルフラフィン塩酸塩含有カプセル製剤
RU2017145602A (ru) * 2015-05-29 2019-07-02 Кил Лэборетериз, Инк. Жидкие композиции целекоксиба для перорального введения
US11278506B2 (en) 2015-10-09 2022-03-22 Rb Health (Us) Llc Pharmaceutical formulation
WO2018045170A1 (fr) * 2016-09-01 2018-03-08 The Procter & Gamble Company Médicament ayant un goût et une perception sensorielle améliorés
US10576041B2 (en) 2016-09-26 2020-03-03 The Procter & Gamble Company Extended relief dosage form
CN110115708A (zh) * 2018-02-07 2019-08-13 保瑞药业股份有限公司 乙酰胺酚及曲马多共溶复方止痛口服液
US11911517B2 (en) 2018-05-16 2024-02-27 Bayer Healthcare Llc High concentration suspension formulation for cold and flu soft gel capsule medications
CN108434097A (zh) * 2018-06-22 2018-08-24 南京济群医药科技股份有限公司 一种稳定的含盐酸曲普利啶口服溶液剂及其制备方法
CN109010341A (zh) * 2018-10-29 2018-12-18 南京济群医药科技股份有限公司 一种含有氢溴酸右美沙芬的复方口服溶液及其制备方法
CN113966223A (zh) 2019-04-11 2022-01-21 R·P·舍勒科技有限责任公司 用于有不良渗透性的蛋白质、肽和小分子的口服递送的制剂
ES2969035T3 (es) * 2019-12-23 2024-05-16 Nutra Essential Otc S L Composición líquida que comprende ibuprofeno y fenilefrina
WO2021150747A1 (fr) * 2020-01-22 2021-07-29 Nevakar Inc. Compositions et récipients de chlorhydrate de phényléphrine
CN111773203B (zh) * 2020-05-15 2024-11-26 北京博智绿洲医药科技有限公司 一种包含盐酸去氧肾上腺素组合物的制备工艺
CN111803452A (zh) * 2020-07-08 2020-10-23 北京博达绿洲医药科技研究有限公司 一种包含盐酸去氧肾上腺素组合物的泡腾颗粒剂制备工艺
CN114533664B (zh) * 2022-01-29 2023-03-31 江苏广承药业有限公司 一种氢溴酸右美沙芬和愈创木酚甘油醚复方口服液体制剂

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3515781A (en) * 1967-10-12 1970-06-02 Johnson & Johnson Cold capsule
US5616621A (en) * 1995-01-30 1997-04-01 American Home Products Corporation Taste masking liquids
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
EP0901787B1 (fr) * 1997-09-10 2003-05-28 Takeda Chemical Industries, Ltd. Composition pharmaceutique stabilisée
US6287597B1 (en) 1999-03-12 2001-09-11 Carter-Wallace, Inc. Antihistaminic/decongestant compositions
JP3450805B2 (ja) * 2000-08-08 2003-09-29 わかもと製薬株式会社 水性医薬組成物
AU2002324579B2 (en) 2001-07-31 2007-11-15 Wyeth Sucralose formulations to mask unpleasant tastes
US6462094B1 (en) * 2001-08-22 2002-10-08 Medpointe Healthcare Inc. Decongestant/expectorant compositions
US6509492B1 (en) * 2001-08-31 2003-01-21 First Horizon Pharmaceutical Corporation Tannate compositions and methods of treatment
US20030060422A1 (en) * 2001-08-31 2003-03-27 Balaji Venkataraman Tannate compositions and methods of treatment
US20040132827A1 (en) 2001-10-26 2004-07-08 Pediamed Pharmaceuticals, Inc. Phenylephrine tannate, pyrilamine tannate and dextromethorphan tannate salts in pharmaceutical compositions
US7101572B2 (en) * 2001-12-07 2006-09-05 Unilab Pharmatech, Ltd. Taste masked aqueous liquid pharmaceutical composition
JPWO2004037293A1 (ja) 2002-10-22 2006-02-23 大日本住友製薬株式会社 安定化組成物
US6979689B2 (en) 2002-12-20 2005-12-27 Pediamed Pharmaceuticals, Inc. Compositions and methods for treating upper respiratory congestion
JP2004300138A (ja) * 2003-03-18 2004-10-28 Takeda Chem Ind Ltd 安定化された経口固形製剤
US20050152967A1 (en) 2003-03-28 2005-07-14 Pfab, Lp Dynamic variable release
DE10358213A1 (de) 2003-12-12 2005-07-28 Clariant Gmbh Polyethylenglykol und dessen Herstellung
US20050266031A1 (en) 2004-05-25 2005-12-01 Jay Dickerson Pharmaceutical suspension composition
WO2006022996A2 (fr) 2004-08-04 2006-03-02 Sovereign Pharmaceuticals, Ltd. Forme posologique contenant des medicaments multiples
US20060148837A1 (en) 2005-01-04 2006-07-06 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20070098785A1 (en) * 2005-11-02 2007-05-03 Tim Clarot Medicant delivery system and device
US20070160689A1 (en) * 2006-01-12 2007-07-12 Everett Laboratories, Inc. Compositions and methods for treatment of coughing, sneezing, rhinorrhea, and/or nasal obstruction
US20070254027A1 (en) * 2006-04-28 2007-11-01 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness

Also Published As

Publication number Publication date
PL2040672T3 (pl) 2015-07-31
ES2537761T3 (es) 2015-06-11
JP2009543777A (ja) 2009-12-10
CN101500539A (zh) 2009-08-05
IL196447A0 (en) 2009-09-22
BRPI0714399B8 (pt) 2021-05-25
KR20140088234A (ko) 2014-07-09
CA2657611A1 (fr) 2008-01-17
BRPI0714399B1 (pt) 2020-11-17
NZ574148A (en) 2012-07-27
ZA200900315B (en) 2009-12-30
ECSP099072A (es) 2009-02-27
CN104546671A (zh) 2015-04-29
EP2351554A1 (fr) 2011-08-03
KR20090040334A (ko) 2009-04-23
EP2351554B1 (fr) 2015-09-09
MX2009000530A (es) 2009-01-27
EP2040672A2 (fr) 2009-04-01
AU2007272961A1 (en) 2008-01-17
US20080014274A1 (en) 2008-01-17
SG173354A1 (en) 2011-08-29
TW200812640A (en) 2008-03-16
RU2468787C2 (ru) 2012-12-10
ES2550036T3 (es) 2015-11-04
WO2008008364A2 (fr) 2008-01-17
HUE025790T2 (hu) 2016-05-30
RU2009101295A (ru) 2010-08-27
CO6180496A2 (es) 2010-07-19
PT2351554E (pt) 2015-11-02
HUE025694T2 (hu) 2016-04-28
BRPI0714399A2 (pt) 2013-03-12
EP2040672B1 (fr) 2015-04-01
PL2351554T3 (pl) 2016-01-29
PE20081003A1 (es) 2008-07-13
PT2040672E (pt) 2015-07-02
AU2007272961B2 (en) 2011-07-28
WO2008008364A3 (fr) 2008-05-22
SG10201408522UA (en) 2015-02-27
HK1128886A1 (en) 2009-11-13
IL196447A (en) 2015-06-30
AR061985A1 (es) 2008-08-10
UY30484A1 (es) 2008-02-29

Similar Documents

Publication Publication Date Title
US11406712B2 (en) Phenylephrine-containing liquid formulations
EP2040672B1 (fr) Compositions liquides de phényléphrine à stabilité améliorée
US9744133B2 (en) Enhanced stability of novel liquid compositions
HK1131068A (en) Enhanced stability phenylephrine liquid compositions
HK1128886B (en) Enhanced stability phenylephrine liquid compositions
HK1123993B (en) Phenylephrine-containing liquid formulations
HK1123993A (en) Phenylephrine-containing liquid formulations